Search for: "Gilead Tenofovir Cases"
Results 1 - 20
of 28
Sorted by Relevance
|
Sort by Date
25 Oct 2017, 9:02 am
", [2017] EWHC 13 (Pat)).Teva (or rather Mepha, its Swiss subsidiary) sought a declaration of invalidity of Gilead’s Swiss SPC for the combination of tenofovir disoproxil and emtricitabine. [read post]
16 Jan 2024, 8:02 am
Gilead Tenofovir Cases, No. [read post]
30 Mar 2013, 8:18 pm
In the present case, the CCI did not even find it necessary to refer the case to the DG or issue notice to Gilead and has instead directly rejected the case. [read post]
25 Jul 2007, 12:42 pm
Patents Nos. 5,922,695, 5,935,946, 5,977,089 and 6,043,230, relate to the drug known generically as tenofovir disoproxil fumarate (TDF). [read post]
19 Dec 2019, 9:41 am
"So thus, Case C-121/17 was born. [read post]
25 Jan 2017, 11:25 pm
As well as the TRUVADA® combination product, Gilead markets VIREAD®, a monotherapy (tenofovir), but has not obtained an SPC for it. [read post]
30 Jan 2024, 4:32 am
The active ingredient in Truvada is tenofovir disoproxil fumarate or “TDF” which was developed by Truvada’s manufacturer, Gilead Pharmaceuticals. [read post]
31 Mar 2017, 7:35 am
In the past three months, Mr Justice Arnold has decided three SPC cases - Teva v Gilead [2017] EWHC 13, Abraxis v Comptroller General of Patents [2017] EWHC 14 and, last week, Teva v MSD [2017] EWHC 539. [read post]
30 Apr 2019, 7:22 am
In that case Gilead’s SPC was for tenofovir plus emtricitabine, whereas the relevant patent claimed tenofovir and optionally “other therapeutic ingredients”. [read post]
31 May 2018, 3:02 pm
The FDA approved generic Truvada in 2017, with Teva and Gilead making a deal. [read post]
1 Apr 2008, 2:32 am
There is no unitary European supplementary protection certificate, but national ones only.According to Burrows,In [in Re Gilead Sciences, Inc.] an application was made for an SPC in respect of EP (UK) 0 915 894 and the combination of two antiretroviral compounds, namely tenofovir disoproxil and emtricitabine. [read post]
23 Sep 2017, 7:02 am
THE SPC BLOGTenofovir - High Court Decision in France Those following the tenofovir SPC litigation in Europe will be pleased to hear that the High Court of Paris has recently handed down a decision in relation to Gilead's SPC based on EP0915894. [read post]
3 Aug 2018, 8:22 am
Awaiting Warner-Lambert v ActavisOver at the IP Alchemist blog, former Kat Darren Smyth takes a look at the recent decision from the CJEU in the case of Teva v Gilead C-121/17: Teva v Gilead – C-121/17 provides some clarity on combination products. [read post]
4 Feb 2008, 1:07 pm
WARF Stem Cell patents and Gilead Tenofovir (AIDS drug) patents have had all claims non-finally rejected, but are still pending. [read post]
5 Oct 2020, 2:00 am
Over to Raphaëlle, Julie, Luca and Camille:"After the mid-year round up of Dutch and German patent litigation posted by our Kat's friends at Brinkhof and Arnold Ruess, here comes the French one.In this post, we will report on 4 noticeable patent cases of the French Courts in the first half of 2020:The first two are landmark cases dealing with conflicts of jurisdiction in the context of multi-jurisdictional litigation and clearly show that the French Courts will… [read post]
1 Aug 2008, 4:53 pm
Gilead Science managed to win an appeal against an refusal to grant an SPC for a tenofovir patent, thanks to Mr Justice Kitchin. [read post]
9 Dec 2009, 3:59 pm
Teva Pharmaceuticals (PATracer) Viread (Tenofovir) – India: Gilead files appeal in IPAB challenging IPO’s rejection of Viread patents (GenericsWeb) Yaz (Drospirenone, Ethinyl estradiol) – Canada: Court dismisses judicial review of Minister’s decision refusing to list formulation patent on the Patent Register: Bayer v Canada (Health) (Pharmacapsules @ Gowlings) [read post]
22 Nov 2017, 3:14 am
No prizes for guessing which party was attacking which mark.IP Federation declares no role for IP disputes in proposed Hague Convention, while INTA takes a different approachAnnsley talks us through a new draft legislative instrument - the draft Hague Convention on the Recognition and Enforcement of Foreign Judgments.Book review: Grounds of the Immaterial - A Conflict-based Approach to Intellectual Property RightsMathilde reviews Niels van Dijk’s book, Grounds of the Immaterial, A… [read post]
3 Feb 2010, 2:00 am
(Docket Report) Sustiva (Efavirenz) – US: Mylan and Matrix fail in bid to dismiss Sustiva case brought by Bristol Myer Squibb (Patent Docs) Temodar (Temozolomide) – US: District Court Delaware: Temador patent unenforceable due to prosecution laches and inequitable conduct: Cancer Research Tech v Barr Labs (Docket Report) (Patent Baristas) (IP Factor) Viread (Tenofovir) – US: Gilead Sciences announces notification of Teva’s ANDA filing for Viread… [read post]
15 Feb 2011, 5:26 pm
(FDA Law Blog) Diovan (Vasartan) – France: Novartis v Actavis – preliminary injunction for Valsartan confirmed (The SPC Blog) Diovan HTC (Valsartan) – Belgium: Antwerp Court of Appeal stops infringement of Valsartan/HCTZ SPC based on patent claiming Valsartan alone: Novartis v Teva (The SPC Blog) Lescol (Fluvastatin) – US: Novartis files patent infringement complaint against Mylan following Para IV challenge (Patent Docs) (GenericsWeb) Mucinex (Guaifenesin) – US: Watson… [read post]
